76956-02-0
76956-02-0 结构式
基本信息
中文别名
拉伏替丁 英文别名
Loxtidinaloxtidine
AH-234844
Lavoltidine
Lavoltidina
Lavoltidinum
Lavoltidine [inn:ban]
Lavoltidinum [inn-latin]
Lavoltidina [inn-spanish]
86160-82-9 (Hemisuccinate[1:1])
常见问题列表
生物活性
Lavoltidine (Loxtidine) 是一种具有口服活性的,不可逆且高效的组胺 H2 受体拮抗剂。Lavoltidine 强烈抑制胃酸分泌,并诱发高胃泌素血症。靶点
H 2 Receptor
|
体内研究
Lavoltidine (Loxtidine; 0.5 g/L; orally (drinking water); changed weekly; for 3 months) shows partial suppression of both gastric acid secretion and progression to neoplasia. Lavoltidine inhibits gastric atrophy, hyperplasia, and dysplasia in
H felis
-infected INS-GAS mice.
Lavoltidine treatment for 6 months inhibits gastric tumors in
H felis
-infected INS-GAS mice.
Animal Model: | Male hypergastrinemic mice (INS-GAS mice) infected with Helicobacter felis |
Dosage: | 0.5 g/L |
Administration: | Orally (drinking water); changed weekly; for 3 months |
Result: | Showed partial suppression of both gastric acid secretion and progression to neoplasia. |